LifeClean International AB (DE:651)
FRANKFURT:651
651 Stock Chart & Stats
€0.01
>-€0.01(-1.25%)
At close: 4:00 PM EST
€0.01
>-€0.01(-1.25%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.07
Previous CloseN/A
Volume0.00
Average Volume (3M)2.00K
Market Cap
€4.16M
Enterprise Value€32.90M
Total Cash (Recent Filing)€2.14M
Total Debt (Recent Filing)€21.37M
Price to Earnings (P/E)―
Beta9.92
Next Earnings
Jul 15, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.12
Shares Outstanding1,025,575,800
10 Day Avg. Volume0
30 Day Avg. Volume2,000
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)7.74
Price to Sales (P/S)0.48
P/FCF Ratio-0.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)€12.49M
Bulls Say, Bears Say
Bulls Say
Revenue Growth MomentumSustained ~20% TTM revenue growth indicates improving market traction for LifeClean's products and services. Durable top-line momentum over recent periods signals product adoption and expanding customer uptake, which can underpin future margin recovery if cost structure and scale efficiencies follow.
Proprietary Product & Market FitOwning proprietary disinfection chemistry and bundled implementation services provides a structural competitive advantage in professional/healthcare markets. This differentiated product set supports repeat institutional demand and creates higher switching costs versus commodity suppliers, aiding longer-term revenue durability.
Declining Absolute Debt LevelsReduction in absolute debt levels signals active balance-sheet repair and lowers immediate refinancing pressure. A meaningful decline in borrowings improves near-term liquidity headroom and gives management more optionality to prioritize operational fixes or fund targeted growth without immediate reliance on dilutive capital raises.
Bears Say
Negative Gross Profit & Deep LossesNegative gross profit and a ~-61% TTM net margin reveal unprofitable unit economics and a broken cost base. Absent structural cost reductions or pricing power, persistent negative margins undermine scalability and mean the business cannot self-fund growth, requiring durable corrective actions or external capital.
Persistent Operating Cash BurnConsistent negative operating and free cash flow (~-22.7m TTM) drains liquidity and forces dependence on financing. Ongoing cash burn reduces runway for investment, elevates refinancing or dilution risk, and constrains the firm's ability to sustain commercial initiatives needed to achieve profitable scale.
High Leverage On Thin Equity BaseVery high debt-to-equity and a thin/negative equity base sharply raise refinancing and covenant risks. Leverage on a weak capital base limits financial flexibility, increases funding costs, and makes the company vulnerable to adverse shocks or the need for dilutive recapitalization to stabilize the balance sheet.
LifeClean International AB News
651 FAQ
What was LifeClean International AB’s price range in the past 12 months?
LifeClean International AB lowest stock price was <€0.01 and its highest was €0.07 in the past 12 months.
What is LifeClean International AB’s market cap?
LifeClean International AB’s market cap is €4.16M.
When is LifeClean International AB’s upcoming earnings report date?
LifeClean International AB’s upcoming earnings report date is Jul 15, 2026 which is in 32 days.
How were LifeClean International AB’s earnings last quarter?
LifeClean International AB released its earnings results on Apr 29, 2026. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.002.
Is LifeClean International AB overvalued?
According to Wall Street analysts LifeClean International AB’s price is currently Overvalued.
Does LifeClean International AB pay dividends?
LifeClean International AB does not currently pay dividends.
What is LifeClean International AB’s EPS estimate?
LifeClean International AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LifeClean International AB have?
LifeClean International AB has 1,025,575,800 shares outstanding.
What happened to LifeClean International AB’s price movement after its last earnings report?
LifeClean International AB reported an EPS of -€0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of LifeClean International AB?
Currently, no hedge funds are holding shares in DE:651
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
LifeClean International AB
LifeClean International AB (publ) is a Swedish company that engages in the comprehensive process of investigating, manufacturing, promoting, and distributing disinfection agents within Sweden. A key innovation from the company is its patented surface disinfectant. This powerful formula is engineered to eradicate a wide array of harmful microorganisms, including spores, fungi, tenacious biofilms, bacteria, and viruses. It is designed for versatile application across various equipment and surfaces, encompassing flooring, walls, furniture, and overhead structures. The enterprise was founded in 2012 and maintains its operational base in Uddevalla, Sweden.